GO:0001787 natural killer cell proliferation

Natural killer (NK) cells are innate lymphoid cells that provide rapid defense against virally infected and transformed cells. The expansion of a natural killer cell population by cell division, formally annotated as GO:0001787 natural killer cell proliferation, is a fundamental biological process that determines the size and functional capacity of the NK cell compartment. This process is not merely a passive response to infection but is actively regulated by a network of cytokines, transcription factors, and metabolic cues that ensure adequate NK cell numbers while preventing excessive or autoreactive responses. Understanding NK cell proliferation is critical for researchers in immunology, oncology, and immunotherapy because the success of NK cell-based therapies depends on the ability to expand functional NK cells ex vivo and in vivo. The process of NK cell proliferation is initiated when quiescent NK cells receive proliferative signals, most notably through cytokine receptors that respond to interleukin-2 (IL-2) and interleukin-15 (IL-15). These signals drive entry into the cell cycle, DNA replication, and mitosis, resulting in clonal expansion of NK cells with preserved or enhanced effector functions. Recent studies have shown that cytokine-induced memory-like NK cells exhibit enhanced proliferation and potent responses against myeloid leukemia, highlighting the therapeutic potential of manipulating this process. Moreover, species-specific metabolic requirements, such as serine metabolism, differentially control NK cell functions and proliferation, underscoring the complexity of the regulatory landscape. For researchers, GO:0001787 represents a convergence point for studies on NK cell homeostasis, immunotherapy, and antiviral defense. The ability to measure and manipulate NK cell proliferation is essential for developing next-generation NK cell therapies, including CAR-NK cells and memory-like NK cells. This article provides a comprehensive overview of the definition, mechanisms, key genes, disease relevance, and research methods associated with natural killer cell proliferation, with a focus on CRISPR-based approaches for functional dissection.

GO:0001787 natural killer cell proliferation is defined as the expansion of a natural killer cell population by cell division. This biological process encompasses the series of molecular and cellular events that lead to an increase in NK cell numbers, including cell cycle entry, DNA replication, and mitosis. It is distinct from NK cell differentiation or activation, although these processes are often coordinated. The synonym NK cell proliferation is commonly used in the literature.

Natural killer cell proliferation is critically important because it determines the size and functional capacity of the NK cell compartment, which is essential for early defense against viral infections and tumors. In immunotherapy, the ability to expand NK cells ex vivo or in vivo directly impacts the efficacy of NK cell-based treatments, including cytokine-induced memory-like NK cells that show enhanced responses against myeloid leukemia. Dysregulated NK cell proliferation can lead to inadequate immune responses or contribute to pathology, making it a key area of research in immunology and oncology.

The following genes and proteins are central to the regulation and execution of natural killer cell proliferation, based on published literature.

Natural killer cell proliferation is regulated by a complex network of extrinsic and intrinsic factors. Extrinsic regulation is mediated by cytokines such as IL-2, IL-15, and IL-21, which bind to receptors on NK cells and activate signaling pathways including JAK-STAT and mTOR. Intrinsic regulation involves transcription factors such as STAT5, MYC, and FOXO1, as well as cell cycle regulators like cyclins and CDK inhibitors. Metabolic pathways, including serine metabolism, have been shown to differentially control NK cell functions and proliferation in a species-specific manner, highlighting the interplay between metabolism and proliferation. Additionally, clonality of NK cell expansion is influenced by both extrinsic drivers, such as cytokine availability, and intrinsic factors, including epigenetic modifications.

NK cell proliferation is critical for cancer immunosurveillance, as expanded NK cells can recognize and kill tumor cells. However, tumors can evade NK cell responses by suppressing NK cell proliferation through immunosuppressive cytokines or metabolic competition. In glioblastoma multiforme, prospective molecular targets for NK cell immunotherapy are being investigated to enhance NK cell proliferation and cytotoxicity. Dysregulated NK cell proliferation is also observed in hematologic malignancies, where leukemic cells may inhibit NK cell expansion.

During viral infections, NK cells undergo robust proliferation to control viral replication. NK cell effector functions in antiviral defense depend on the expansion of virus-specific or activated NK cells. Impaired NK cell proliferation can lead to viral persistence and severe disease, as seen in certain viral infections.

The success of NK cell-based immunotherapy relies on the ability to expand NK cells to sufficient numbers while maintaining their effector functions. Cytokine-induced memory-like NK cells exhibit enhanced proliferation and responses against myeloid leukemia, demonstrating the therapeutic potential of manipulating NK cell proliferation. Process engineering of NK cell-based immunotherapy focuses on optimizing expansion protocols to generate clinical-grade NK cell products.

Flow cytometry using dyes such as CFSE or CellTrace Violet is a standard method to measure NK cell proliferation by tracking dye dilution over successive divisions. This method allows quantification of division rounds and identification of proliferating NK cell subsets.

Ex vivo expansion of NK cells using cytokines such as IL-2, IL-15, and IL-21 is widely used to study NK cell proliferation and to generate cells for immunotherapy. These protocols can be combined with feeder cells or artificial antigen-presenting cells to enhance expansion.

CRISPR-Cas9 knockout, knock-in, and overexpression are powerful tools to dissect genes regulating NK cell proliferation. These approaches enable loss-of-function and gain-of-function studies in primary NK cells and NK cell lines.

Metabolic assays, such as Seahorse extracellular flux analysis and metabolomics, are used to study the metabolic requirements of NK cell proliferation, including serine metabolism.

Researchers studying natural killer cell proliferation-related genes often need to determine whether a candidate gene is causally involved in NK cell expansion, and CRISPR-based models provide the most direct approach. EDITGENE offers a comprehensive suite of services to support these investigations, from knockout and point mutation to knock-in and overexpression, as well as library screening and bioinformatics.

Natural killer cell proliferation (GO:0001787) is a fundamental biological process that governs the expansion of NK cells in response to cytokines and activation signals. It is essential for antiviral defense, cancer immunosurveillance, and the efficacy of NK cell-based immunotherapies. Understanding the genes and pathways that regulate NK cell proliferation, such as IL-15/STAT5 signaling and metabolic checkpoints, provides opportunities for therapeutic intervention. CRISPR-based models are indispensable for dissecting the causal roles of candidate genes in NK cell proliferation. EDITGENE offers a full range of services, including knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics, to support researchers in this rapidly evolving field.